Explore
Validate
Learn
Western blot
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [4]
- Immunoprecipitation [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN396013 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Fatty Acid Synthase (FASN) (AA 1-440) antibody
- Antibody type
- Monoclonal
- Description
- Purified
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 1-440
- Isotype
- IgG
- Antibody clone number
- 3F2-1F3
- Vial size
- 50 μg
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.Preca
Submitted references Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival.
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Extracellular fatty acid synthase: a possible surrogate biomarker of insulin resistance.
Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase.
Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?
Nguyen PL, Ma J, Chavarro JE, Freedman ML, Lis R, Fedele G, Fiore C, Qiu W, Fiorentino M, Finn S, Penney KL, Eisenstein A, Schumacher FR, Mucci LA, Stampfer MJ, Giovannucci E, Loda M
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Sep 1;28(25):3958-64
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Sep 1;28(25):3958-64
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S, DREAM investigators.
Diabetes care 2010 Oct;33(10):2250-3
Diabetes care 2010 Oct;33(10):2250-3
Extracellular fatty acid synthase: a possible surrogate biomarker of insulin resistance.
Fernandez-Real JM, Menendez JA, Moreno-Navarrete JM, Blüher M, Vazquez-Martin A, Vázquez MJ, Ortega F, Diéguez C, Frühbeck G, Ricart W, Vidal-Puig A
Diabetes 2010 Jun;59(6):1506-11
Diabetes 2010 Jun;59(6):1506-11
Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase.
Zeng L, Biernacka KM, Holly JM, Jarrett C, Morrison AA, Morgan A, Winters ZE, Foulstone EJ, Shield JP, Perks CM
Endocrine-related cancer 2010 Jun;17(2):539-51
Endocrine-related cancer 2010 Jun;17(2):539-51
Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?
Ruaño G, Thompson PD, Kane JP, Pullinger CR, Windemuth A, Seip RL, Kocherla M, Holford TR, Wu AH
Pharmacogenomics 2010 Jul;11(7):959-71
Pharmacogenomics 2010 Jul;11(7):959-71
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IP
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
